About this trial
This project aims to document and analyse - with a three-fold anthropological, psychosocial and economical approach - the consequences of the geographical distance from mainland France on the alloSCT on both patients, their caregivers and the healthcare system. It is organised in 3 working packages (WP).
Eligibility criteria
Qualifiers
patients diagnosed with hematological malignancy (myeloid acute leukemia, lymphoid acute leukemia, non-hodgkin lymphoma, Hodgkin disease, or myelodysplasic syndrome
candidate to an allogeneic hematopoietic stem cell transplantation in mainland France ;
Residing in Reunion Island
Age >18 year old;
Disqualifiers
Opposition to participation and collection of their data
Person deprived of liberty by judicial or administrative decision, and person subject to legal protection (guardianship or curators)
Trial design
Treatments tested in this trial
- questionnaire
Treatment groups
Sponsors and collaborators
Centre Hospitalier Universitaire de la Réunion
Lead sponsor
Institut Paoli-Calmettes
Collaborator